Remynd Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 59
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 10

Remynd General Information

Description

Developer of tools and services designed to help in the treatment of Alzheimer's, Parkinson's, diabetes and other diseases. The company is a contract research organization (CRO) with extensive experience in the testing of experimental Alzheimer therapies in its proprietary transgenic mouse models and actively drives research and development in the field of protein misfolding diseases, enabling patients to address key challenges at the root.

Contact Information

Website
www.remynd.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Biotechnology
Primary Office
  • Gaston Geenslaan 1
  • Heverlee
  • 3001 Leuven
  • Belgium
+32 016 00 00 00

Remynd Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Remynd Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Remynd‘s full profile, request access.

Request a free trial

Remynd Executive Team (9)

Name Title Board Seat Contact Info
Koen de Witte Managing Director & Board Member
Gerard Griffioen Ph.D Chief Scientific Officer
Lode Debrabandere Ph.D Chief Business Officer
Joris Winderickx Ph.D Co-Founder and Scientific Advisor
Fred Van Leuven Ph.D Scientific Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

Remynd Board Members (8)

Name Representing Role Since
0000 000000 Self Board Member 000 0000
00000 00 000000 00.0 PMV Board Member 000 0000
000000000 0000 Korys Investments Board Member 000 0000
0000000 0000 Self Board Member 000 0000
0000 00 00000 Remynd Managing Director & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Remynd Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Remynd Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Remynd‘s full profile, request access.

Request a free trial